Killeen Anthony A, Long Tom, Souers Rhona, Styer Patricia, Ventura Christina B, Klee George G
From the Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis (Dr Killeen); the Department of Biostatistics (Mr Long, Ms Souers, and Dr Styer) and the Instrumentation Resource Committee (Ms Ventura), College of American Pathologists, Northfield, Illinois; and the Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota (Dr Klee).
Arch Pathol Lab Med. 2014 Sep;138(9):1173-81. doi: 10.5858/arpa.2013-0051-CP.
Both the regulations in the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and the checklists of the College of American Pathologists (CAP) Laboratory Accreditation Program require clinical laboratories to verify performance characteristics of quantitative test systems. Laboratories must verify performance claims when introducing an unmodified, US Food and Drug Administration-cleared or approved test system, and they must comply with requirements for periodic calibration and calibration verification for existing test systems. They must also periodically verify the analytical measurement range of many quantitative test systems.
To provide definitions for many of the terms used in these regulations, to describe a set of basic analyses that laboratories may adapt to demonstrate compliance with both CLIA and the CAP Laboratory Accreditation Program checklists for performing calibration verification and for verifying the analytical measurement range of test systems, to review some of the recommended procedures for establishing performance goals, and to provide data illustrating the performance goals used in some of the CAP's calibration verification and linearity surveys.
The CAP's calibration verification and linearity survey programs, the CLIA regulations, the Laboratory Accreditation Program requirements, and published literature were used to meet these objectives.
Calibration verification and linearity and analytical measurement range verification should be performed using suitable materials with assessment of results using well-defined evaluation protocols. We describe the CAP's calibration verification and linearity programs that may be used for these purposes.
1988年《临床实验室改进修正案》(CLIA)中的规定以及美国病理学家协会(CAP)实验室认可计划的检查表都要求临床实验室验证定量检测系统的性能特征。实验室在引入未经修改、经美国食品药品监督管理局批准或认可的检测系统时必须验证性能声明,并且必须遵守现有检测系统的定期校准和校准验证要求。他们还必须定期验证许多定量检测系统的分析测量范围。
为这些规定中使用的许多术语提供定义,描述一组基本分析方法,实验室可采用这些方法来证明符合CLIA和CAP实验室认可计划检查表中关于进行校准验证和验证检测系统分析测量范围的要求,回顾一些用于设定性能目标的推荐程序,并提供数据说明CAP校准验证和线性度调查中使用的性能目标。
CAP的校准验证和线性度调查计划、CLIA规定、实验室认可计划要求以及已发表的文献用于实现这些目标。
校准验证、线性度和分析测量范围验证应使用合适的材料进行,并使用明确的评估方案对结果进行评估。我们描述了可用于这些目的的CAP校准验证和线性度计划。